Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that on Dec. 18, 2023, the Compensation Committee of its Board of Directors.
Short Interest in Castle Biosciences, Inc (NASDAQ:CSTL) Drops By 9 2% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 1,180,000 shares, a decrease of 9.2% from the November 15th total of 1,300,000 shares. Based on an average daily trading volume, of 253,300 […]
Guggenheim Initiates Coverage on Castle Biosciences (NASDAQ:CSTL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 6,875 shares of the company’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $20.09, for a total transaction of $138,118.75. Following the completion of the sale, the director now directly owns 50,605 […]